Tracking Medicare news, policy, and coverage changes.
As the Human Cell Atlas project marks its 10th anniversary, a leader's ties to a major single-cell RNA sequencing company raise conflict-of-interest questions.
Read full article →America’s next health emergency won’t wait for Washington, write W. Craig Vanderwagen and Jennifer B. Alton.
Read full article →“Alzheimer’s is not primarily a disease of old age. It is a decades-long biological process,” writes Elizabeth Bevins.
Read full article →One of the world's leading brain research centers is shifting away from fruit flies and toward a tiny, transparent fish. The goal: to understand how brains control the behavior of an animal or human.
Read full article →The health secretary has visited four House districts with toss-up races in the last six weeks.
Read full article →MultiCare CFO James Lee said decades of government underpayment have pushed U.S. healthcare to a breaking point. He thinks the nation is headed toward a two-tier system — one for patients with commercial coverage, and another for those covered through CMS. The post Multicare CFO: Decades of CMS Underpayment is Creating an Unfair Two-Tiered System appeared first on MedCity News .
Read full article →Elevance Health is leveraging AI for simplifying the member experience, improving the provider experience and making sure employees have the right information at the right time. The post Elevance Health’s 3 Key Priorities for AI appeared first on MedCity News .
Read full article →The FDA said it will allow Colorado to import certain prescription drugs from Canada in an effort to bring prices down for residents.
Read full article →(MedPage Today) -- Older adults at higher risk for dementia were less likely to have a dementia diagnosis if they received a herpes zoster (shingles) shot, a cohort study using target trial emulation showed. Among 500,000 people in skilled-nursing...
Read full article →(MedPage Today) -- Reminders, or "nudges," to both oncology clinicians and patients led to a significant increase in difficult conversations about poor-prognosis cancers, a large randomized study showed. Involving more than 1,000 patients and...
Read full article →(MedPage Today) -- Replacing two high-dose chemotherapy courses with blinatumomab (Blincyto) significantly improved event-free survival (EFS) in pediatric patients with newly diagnosed high-risk B-cell acute lymphoblastic leukemia (ALL), an interim...
Read full article →(MedPage Today) -- The FDA cleared the first over-the-counter (OTC) integrated continuous glucose monitor (CGM) for children 2 years and older with or without diabetes, the agency announced on Friday. The Stelo Glucose Biosensor System device...
Read full article →